Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Fibroblast Growth Factor-23 (FGF-23) Levels Are Independently Associated With Left Ventricular Mass and Myocardial Performance Index in Maintenance Haemodialysis Patients

NCT01154842 is registered in ClinicalTrials.gov with Diskapi Teaching and Research Hospital as lead sponsor.

NCT NCT01154842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01154842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Fibroblast Growth Factor-23 (FGF-23) Levels Are Independently Associated With Left Ventricular Mass and Myocardial Performance Index in Maintenance Haemodialysis Patients
Lead sponsor
Diskapi Teaching and Research Hospital
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2009
Completion date
June 30, 2010
Enrollment
128 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibroblast